Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab Meeting Abstract


Authors: Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; Busam, K. J.; Feely, W.; Jure-Kunkel, M.; Grosso, J.; Simon, J. S.; Korman, A. J.; Wigginton, J. M.; Gupta, A. K.; Zhang, X.; Phillips, T.; Simmons, P.; Sznol, M.; Wolchok, J. D.
Abstract Title: Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
Meeting Title: 28th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 1
Issue: Suppl. 1
Meeting Dates: 2013 Nov 8-10
Meeting Location: National Harbor, MD
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2013-11-07
Language: English
DOI: 10.1186/2051-1426-1-S1-O6
PROVIDER: manual
PMCID: PMC3991225
Notes: Meeting Abstract: O6
Altmetric Score
MSK Authors
  1. Jedd D Wolchok
    669 Wolchok
  2. Margaret Kathleen Callahan
    103 Callahan
  3. Charlotte Eielson Ariyan
    78 Ariyan
  4. Michael Andrew Curran
    14 Curran
  5. David A Schaer
    21 Schaer
  6. Jianda Yuan
    100 Yuan
  7. Shigehisa Kitano
    10 Kitano
  8. Klaus J Busam
    540 Busam
  9. Alexander Meyer Lesokhin
    118 Lesokhin